Caricamento...
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives
Minimal residual disease (MRD) detection represents a sensitive tool to appropriately measure the response obtained with therapies for multiple myeloma (MM). The achievement of MRD negativity has superseded the conventional complete response (CR) and has been proposed as a surrogate endpoint for pro...
Salvato in:
| Pubblicato in: | J Clin Med |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7408660/ https://ncbi.nlm.nih.gov/pubmed/32645952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072142 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|